Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sezary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project

Please use this identifier to cite or link to this item: http://scholars.ntou.edu.tw/handle/123456789/1297

Title:	Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sezary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project
Authors:	Kim, Y. H. Tavallaee, M. Sundram, U. Salva, K. A. Wood, G. S. Li, S. F. Rozati, S. Nagpal, S. Krathen, M. Reddy, S. Hoppe, R. T. Nguyen-Lin, A. Wen-Kai Weng Armstrong, R. Pulitzer, M. Advani, R. H. Horwitz, S. M.
Issue Date:	Nov-2015
Journal Volume:	33
Journal Issue:	32
Source:	Journal of Clinical Oncology
URI:	http://scholars.ntou.edu.tw/handle/123456789/1297
ISSN:	0732-183X
DOI:	10.1200/jco.2014.60.3969 ://WOS:000366020100014
Appears in Collections:	河海工程學系

Show full item record

Last Week
0

Last month
0

checked on Oct 13, 2022

Check

DSpace CRIS